The higher topline was mainly attributed to an increase in the group’s Diagnostic & Aesthetics business segment, which saw a surge in demand for aesthetics, LASIK and diagnostic imaging related services.
Singapore Medical Group has announced revenue of $24.8 million for the 1QFY2021, making this the group’s all-time quarterly high.
The quarter’s revenue represents a 7.6% y-o-y growth from the corresponding period the year before.
